Teladoc (TDOC) shares are inching up after Citron Research likened them to a “coiled spring” – full of potential, compressed, ...

I maintain my Buy rating on Teladoc Health due to positive acquisitions and a robust balance sheet, despite recent weak Q1 ...

Teladoc Health Inc (NYSE:TDOC) shares are rising Monday after Citron Research made positive comments about the company on its ...

What Happened? Shares of digital medical services platform Teladoc Health (NYSE:TDOC) jumped 10.9% in the afternoon session after Citron Research published a report highlighting the company's growth ...

Teladoc Health stock price surged by over 14% on Monday, its best single-day gain since April 9. What next for the TDOC share ...

Teladoc Health (TDOC) stock rallies as Citron Research issues a bullish report on the company. Read more here.

TDOC is a long way from its February 2021 highs just under $300. The options pits are predominantly focused on calls, despite limited absolute volume. In the past 10 days, ...

In the closing of the recent trading day, Teladoc (TDOC) stood at $7.40, denoting a +1.79% change from the preceding trading day.

Shares of digital medical services platform Teladoc Health (NYSE:TDOC) jumped 10.9% in the afternoon session after Citron Research published a report highlighting the company's growth potential ...